期刊文献+

药物转运体在药物排泄中的作用 被引量:2

原文传递
导出
摘要 目的介绍肾、肝及肠道等器官上分布的药物转运体,阐述相关转运体在药物排泄过程中的作用及基于转运体影响药物排泄的各种因素。方法查阅转运体与药物排泄的相关文献。结果药物转运体与药物在体内的排泄密切相关;疾病、性别及种属等多种因素能够影响药物转运体的表达及其底物药物的排泄。结论深入了解药物排泄中转运体的作用机制,对防范临床联合用药的风险具有重要意义。
出处 《中国药学杂志》 CAS CSCD 北大核心 2013年第8期582-586,共5页 Chinese Pharmaceutical Journal
  • 相关文献

参考文献42

  • 1FROMM M F, KIM R B. Drug Transporters [ M ]. Erlangen: Springer Verlag Berlin Heidelberg, 2011:5.
  • 2HE X, WU W H, OUYANG D S, et al. Progress in transporters of ABCC2 [ J ]. Chin Pharm J , 2007, 42 (23) : 1764-1767.
  • 3MAXEREEUW R, RUSSEL F. Screening for the role of trans- porters in hepatic and renal drug handling [ J ]. Drug Discov To- day, 2004, 1 (4) :357-364.
  • 4SHITARA Y, HORIEA T, SUGIYAMA Y. Transporters as a de- terminant of drug clearance and tissue distribution [ J ]. Eur J Pharm Sci, 2006, 27(5) :425-446.
  • 5SEKINE T, WATANABE N, HOSOYAMADA M, et al. Expres- sion cloning and characterization of a novel multispecific organic anion transporter [ J]. J Biol Chem, 1997, 272 (30) : 18526- 18529.
  • 6SWEET D H, WOLFF N A, PRITCHARD J B. Expression clo- ning and characteri-zation of rOAT1. The basolateral organic ani- on transporter in rat kidney [ J ]. J Biol Chem, 1997, 272 (48) : 30088-30095.
  • 7KOJIMA R, SEKINE T, KAWACHI M, et al. Immunolocaliza- tion of multispecific organic anion transporters, OAT1, OAT2, and OAT3, in rat kidney [J]. J Am Soc Nephrol, 2002, 13 (4) :848-857.
  • 8SEKINE T, CHA S H, TSUDA M,et al. Identification of multi- specific organic anion transporter 2 expressed predominantly in the liver [ J ]. Febs Lett, 1998,429 (2) : 179-182.
  • 9MINEMATSU T, HASHIMOTO T, AOKI T, et al. Role of organ- ic anion trans-porters in the pharmacokinetics of zonampanel, an alpha-amino-3 -hydroxy-5 -methylisoxazole-4 -propionate receptor antagonist, in rats [-J ]. Drug Metab Dispos, 2008, 36 (8): 1496-1504.
  • 10HAN Y H, BUSLER D, HONG Y, et al. Transporter studies with the 3-O-sulfate-conjugate of 17 alpha-ethinylestradiol: As- sessment of human kidney drug transpor-ters [ J ]. Drug Metab Dispos, 2010, 38(7):1064-1071.

同被引文献9

  • 1中国药典[S].二部.2010.
  • 2USP[S].35theds.2012.12.
  • 3FDA. Guidance for Industry Drug Interaction Studies -Study Design, Data Analysis, and Implications for Dosing and Labeling [ S ]. 2006.
  • 4Gao S, Zhou J, Zhang F, et al. Rapid and sensitive liquid chroma- tography coupled with electrospray ionization tandem mass spectrome- try method for the analysis of paclitaxel, docetaxel, vinblastine, and vinorelbine in human plasma [ J l. Talanta, 2013, 116:887-893.
  • 5Kosjek T, Dolin~ek T, Gramec D, et al. Determination of vinblastine in tumour tissue with liquid chromatography-high resolution mass spectrometry[J]. Ther Drug Monit, 2014, 36(3) :394-400.
  • 6Achanta S, Ngo M, Veitenheimer A, et al. Simultaneous quantifica- tion of vinblastine and desacetylvinblastine concentrations in canine plasma and urine samples using LC-APCI-MS/MS [ J ]. J Chromatogr B Analvt Technol Biomed Life Sci. 2013. 913-914:147-154.
  • 7习利平,宋新波,张丽娟.长春碱类抗肿瘤药的研究进展[J].药物评价研究,2011,34(1):59-62. 被引量:20
  • 8汪成进,段成才,胡文浩.非秋水仙碱、长春碱类微管蛋白阻聚剂的研究进展[J].中国药学杂志,2013,48(1):1-8. 被引量:1
  • 9李聃,盛莉,李燕.药物转运体的研究方法[J].药学学报,2014,49(7):963-970. 被引量:19

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部